Whole-body diffusion-weighted magnetic resonance imaging (WB-DW-MRI) vs choline-positron emission tomography-computed tomography (choline-PET/CT) for selecting treatments in recurrent prostate cancer.
Antonio José Conde-MorenoG Herrando-ParreñoR Muelas-SoriaJ Ferrer-RebolledaR Broseta-TorresM P Cozar-SantiagoF García-PiñónC Ferrer-AlbiachPublished in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2016)
Choline-PET/CT has a high global sensitivity while WB-DW-MRI has a high specificity, and so they are complementary techniques. Future studies with more enrolled patients and a longer follow-up period will be required to confirm these data. The initial data show that the best technique for evaluating response after SBRT is choline-PET/CT. Trial registration number NCT02858128.
Keyphrases
- pet ct
- positron emission tomography
- contrast enhanced
- diffusion weighted
- magnetic resonance imaging
- computed tomography
- prostate cancer
- diffusion weighted imaging
- end stage renal disease
- magnetic resonance
- electronic health record
- clinical trial
- newly diagnosed
- chronic kidney disease
- big data
- pet imaging
- radiation therapy
- study protocol
- randomized controlled trial
- peritoneal dialysis
- data analysis
- dual energy
- current status
- open label